Emerging research suggest Retatrutide , a dual activator targeting both GLP-1 and another hormone, may provide a promising step forward for body loss . Preliminary human investigations have demonstrated impressive reductions in body fat , conceivably surpassing current weight-loss treatments. Despite this, further assessment is needed to completely